Article in Device, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Bumseok NamgungCenter for Engineered Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hongqing DaiCenter for Engineered Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Pooja Prathyushaa VikramanCenter for Engineered Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Tanmoy SahaCenter for Engineered Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Shiladitya SenguptaCenter for Engineered Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Hae Lin JangCenter for Engineered Therapeutics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Funding
Engineering personalized micro-tumor ecosystemsU01CA214411 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI KHADEMHOSSEINI, ALI, SENGUPTA, SHILADITYA · 2017 to 2021
$3.5M
A novel bioengineering approach to restoring permanent periodontal inflammatory bone lossR01DE032406 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI Hae Lin Jang · 2023 to 2026
$3.3M
Tunneling Nanotube Inhibitors for Cancer ImmunotherapyR01CA276525 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI Shiladitya Sengupta · 2023 to 2026
$3.0M
Whitlockite nanoparticle-based immunotherapy for bone metastasisR01CA236702 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI JANG, HAE LIN, SENGUPTA, SHILADITYA · 2019 to 2023
$2.7M
3D printed muscle-bone organ implant for treating large injuriesR01AR073135 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DOKMECI, MEHMET REMZI, JANG, HAE LIN · 2018 to 2022
$2.2M
Spatiotemporal delivery of synergistic drug combinations to kidney cancerR01CA229772 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI SABBISETTI, VENKATA · 2018 to 2022
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
An inexpensive "do-it-yourself" device for rapid generation of uniform tumor spheroids. · full record | OpenQuestion